About Minapharm
Minapharm Pharmaceuticals is a leading pharmaceutical company in Egypt and the Middle East with its subsidiary MigenTra Egypt the premier biopharmaceutical company in Africa with over 20 years of experience in cellular and bioprocess engineering.
Headquartered in Cairo, Minapharm commercializes over 100 life-saving and life-enhancing products ranging from small molecules to complex genetically engineered proteins, with an impressive immunotherapy pipeline.
Minapharm’s wholly-owned Berlin-based subsidiary, ProBioGen AG, is a world-renowned contract development and manufacturing organization (CDMO), a cell line-engineering specialist, and a provider of proprietary protein and viral vector technologies to large pharma and the global biotech industry.
Minapharm has established an integrated business model making it to date the only gene-to-market biopharmaceutical company in the region.
Minapharm Group of Pharmaceutical Companies employ a collective workforce of more than1400 individuals & continue to expand their workforce with Talented Human Capital.
Our Core Values:
